Diagnostic Accuracy of Bronchodilator Response for Asthma in a Population of South China

Advances in therapy(2018)

引用 3|浏览13
暂无评分
摘要
Introduction A significant bronchodilator response is commonly defined as a 12% or greater and 200 ml or greater change in FEV 1 from baseline according to the 2005 American Thoracic Society (ATS)/European Respiratory Society (ERS) criterion. A number of studies have shown that the ATS/ERS criterion has limitations in asthma diagnosis, and some experts have argued for correcting the criteria. The aim of this study is to investigate the diagnostic value of acute bronchodilator response for asthma in a Southern Chinese population. Methods We prospectively evaluated 805 patients with obstructive lung disease (309 for asthma, 496 for non-asthma). Spirometry was performed according to the ATS/ERS guidelines. Data were analyzed by SPSS 18.0. The receiver-operating characteristic (ROC) curve was drawn to assess the diagnostic accuracy of the ATS/ERS criterion based on FEV 1 . Linear regression was used to analyze the factors of FEV 1 change. Results The sensitivity and specificity of the acute bronchodilator test when judged by the ATS/ERS criteria (200 ml or higher and 12% improvement) were 68.6% and 78.2%, respectively. For the ATS/ERS criteria, the Youden Index, which comprehensively reflects the authenticity of a diagnostic test, was 46.8%. The absolute change of FEV 1 positively correlated with baseline FEV 1 and weight and negatively with age, while the percentage change of FEV 1 was negatively correlated with baseline FEV 1 , age and height and positively with weight. Compared with the different diagnostic values, when ∆FEV 1 was 195 ml and ∆FEV 1i % was 14%, the Youden Index was the largest (48.2%) and the diagnostic capability of the test the biggest. Conclusions The ATS/ERS criterion for acute bronchodilator response might not be completely suitable for asthma in the Chinese population. Trial Registration Chinese Clinical Trial Registry (Registry ID: ChiCTR-DDT-14004976). Funding This work was supported by the National Natural Science Foundation of China (grant nos. 81670027, 81270080).
更多
查看译文
关键词
ATS/ERS criterion,Asthma,Bronchodilator response,Chinese population
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要